LACOSAMIDE

NDC 50228-192 · ScieGen Pharmaceuticals Inc

Generic nameLACOSAMIDE

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)LACOSAMIDE

Strength50 mg/1

Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]

DEA scheduleCV

Marketing categoryANDA

Packages

50228-192-10 — 1000 TABLET, FILM COATED in 1 BOTTLE (50228-192-10)

50228-192-30 — 30 TABLET, FILM COATED in 1 BOTTLE (50228-192-30)

50228-192-60 — 60 TABLET, FILM COATED in 1 BOTTLE (50228-192-60)

FDA lists these products with the same active ingredient.

33342-305 — Lacosamide, 43598-087 — Lacosamide, 46708-171 — lacosamide, 46708-172 — lacosamide, 46708-173 — lacosamide, 46708-174 — lacosamide, 47335-918 — Lacosamide, 47335-922 — Lacosamide, 47335-943 — Lacosamide, 47335-980 — Lacosamide, 50228-193 — LACOSAMIDE, 50228-194 — LACOSAMIDE, 50228-195 — LACOSAMIDE, 51407-721 — LACOSAMIDE, 51407-722 — LACOSAMIDE, 51407-723 — LACOSAMIDE, 51407-724 — LACOSAMIDE, 51991-348 — LACOSAMIDE, 51991-349 — LACOSAMIDE, 51991-350 — LACOSAMIDE, +141 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.